Tokyo, Feb. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060716) titled 'Questionnaire Survey on Physical and Mental Health in Patients with Rheumatoid Arthritis' on Feb. 24.

Study Type: Observational

Primary Sponsor: Institute - ASAHI KASEI PHARMA CORPORATION

Condition: Condition - Rheumatoid arthritis Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To assess the degree of difficulties and distress related to physical function and mental health in patients with rheumatoid arthritis and to clarify their unmet needs. Additionally, by comparison with healthy individuals, this study aims to elucidate the extent of these difficulties among patients with rheumatoid arthritis. Basic objectives2 - Others

Eligibility: Age-lower limit - 30 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients with Rheumatoid Arthritis 1. Patients with rheumatoid arthritis aged 30 years or older at the time of informed consent. 2. Patients who, at the time of study initiation, are registered in a disease/symptom participant panel owned by INTAGE Inc. 3. Patients who have provided written informed consent by their own will.

Healthy Participants 1. Adults aged 30 years or older at the time of informed consent. 2. Individuals who, at the time of study initiation, are registered in a general consumer panel owned by INTAGE Inc. 3. Individuals who have provided written informed consent by their own will. Key exclusion criteria - Patients with Rheumatoid Arthritis 1.Patients who withdrew their informed consent in writing after the initiation of the study.

Healthy Participants 1. Individuals who currently have rheumatoid arthritis or have been diagnosed with rheumatoid arthritis in the past. 2. Individuals who currently have osteoarthritis or have been diagnosed with osteoarthritis in the past. 3. Individuals with a current diagnosis of cancer. 4. Individuals who have been certified as requiring long-term care. 5. Individuals who possess a physical disability certificate. 6. Individuals who withdrew their informed consent in writing after the initiation of the study. Target Size - 1000

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 12 Month 24 Day Date of IRB - 2026 Year 02 Month 18 Day Anticipated trial start date - 2026 Year 02 Month 25 Day Last follow-up date - 2026 Year 03 Month 04 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069182

Disclaimer: Curated by HT Syndication.